» Articles » PMID: 12610029

The Diabetes Risk Score: a Practical Tool to Predict Type 2 Diabetes Risk

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2003 Mar 1
PMID 12610029
Citations 666
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Interventions to prevent type 2 diabetes should be directed toward individuals at increased risk for the disease. To identify such individuals without laboratory tests, we developed the Diabetes Risk Score.

Research Design And Methods: A random population sample of 35- to 64-year-old men and women with no antidiabetic drug treatment at baseline were followed for 10 years. New cases of drug-treated type 2 diabetes were ascertained from the National Drug Registry. Multivariate logistic regression model coefficients were used to assign each variable category a score. The Diabetes Risk Score was composed as the sum of these individual scores. The validity of the score was tested in an independent population survey performed in 1992 with prospective follow-up for 5 years.

Results: Age, BMI, waist circumference, history of antihypertensive drug treatment and high blood glucose, physical activity, and daily consumption of fruits, berries, or vegetables were selected as categorical variables. Complete baseline risk data were found in 4435 subjects with 182 incident cases of diabetes. The Diabetes Risk Score value varied from 0 to 20. To predict drug-treated diabetes, the score value >or=9 had sensitivity of 0.78 and 0.81, specificity of 0.77 and 0.76, and positive predictive value of 0.13 and 0.05 in the 1987 and 1992 cohorts, respectively.

Conclusions: The Diabetes Risk Score is a simple, fast, inexpensive, noninvasive, and reliable tool to identify individuals at high risk for type 2 diabetes.

Citing Articles

Social and health service-related factors associated with undiagnosed diabetes mellitus- a population-based survey in a highly urbanized Chinese setting.

Poon P, Tam K, Yip B, Chung R, Lee E, Wong S BMC Public Health. 2025; 25(1):900.

PMID: 40050834 PMC: 11887179. DOI: 10.1186/s12889-025-22048-0.


Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society.

Rodacki M, Zajdenverg L, da Silva Junior W, Giacaglia L, Negrato C, Cobas R Diabetol Metab Syndr. 2025; 17(1):78.

PMID: 40038723 PMC: 11881304. DOI: 10.1186/s13098-024-01572-w.


Evaluation of sociodemographic and nutrition-related factors for type 2 diabetes risk: a sample from Turkiye.

Karaca-Celik K, Toprak D, Bas M, Tevfikoglu L, Kahriman M, Ince-Palamutoglu M BMC Public Health. 2025; 25(1):858.

PMID: 40038651 PMC: 11877910. DOI: 10.1186/s12889-025-21940-z.


Development and validation of a Non-INvaSive Pregnancy RIsk ScoRE (INSPIRE) for the screening of high-risk pregnant women for gestational diabetes mellitus in Pakistan.

Naz S, Jamal S, Jaffar A, Azam I, Chandir S, Qureshi R BMJ Public Health. 2025; 2(1):e000920.

PMID: 40018203 PMC: 11812906. DOI: 10.1136/bmjph-2024-000920.


Development and validation of a risk assessment tool for uncontrolled type 2 diabetes among patients in South Karnataka, India.

Anil D, Doddaiah S, Shivaswamy R, Gopi A, Basheer S, Narayana Murthy M BMJ Public Health. 2025; 2(1):e000717.

PMID: 40018133 PMC: 11812843. DOI: 10.1136/bmjph-2023-000717.